Skip to content
PulseMS
Log inJoin
Research & community

MS research, together.

MS research in plain English. Perspectives from people who understand.

Research evidence filters

Filters apply to reviewed research. Unknown dates and unassessed posts are excluded when a corresponding filter is active.

Reset filters
Topics & sourcesFiltered
Research and community updates, newest first.#CARTCellTherapyClear filters
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedNot reportedPeer review unconfirmed

CAR-T Cell Therapy and Gut Microbiota Modulation in MS

Research suggests that CAR-T cells can effectively target and eliminate B cells in multiple sclerosis (MS). Additionally, the gut microbiota is found to play a significant role in immune system balance related to MS.

What this does not proveThe findings do not demonstrate clinical efficacy for CAR-T therapy in MS patients, nor do they clarify how gut microbiota modulation influences MS symptoms or progression.
#CARTCellTherapy#GutMicrobiota#SymptomMgmt#WellnessRelevant to Neurologist, Immunologist
View abstract on PubMedPMID 42793314AI summary of a published abstract. Not medical advice.